Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide

This analysis aimed to investigate whether the long-term administration of temozolomide (TMZ) claimed a survival advantage for patients with glioblastoma in China. A total of 75 patients with newly diagnosed glioblastoma at the Department of Radiation Oncology, Shenzhen People's Hospital betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Rencui, Zhang, Huaqing, Li, Zihuang, Li, Xianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959873/
https://www.ncbi.nlm.nih.gov/pubmed/31914038
http://dx.doi.org/10.1097/MD.0000000000018591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959873/
https://www.ncbi.nlm.nih.gov/pubmed/31914038
http://dx.doi.org/10.1097/MD.0000000000018591

Ejemplares similares